 |
Amifostine |
|---|---|
| Trade Name | Ethyol |
| Orphan Indication | Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer |
| USA Market Approval | USA |
| USA Designation Date | 1998-05-12 00:00:00 |
| Sponsor | Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 |
